Go Deep
Kestra Medical Technologies, Ltd.
Kestra Medical Technologies, Ltd. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 15,749 | -10.1 | 7.22 | 0.34 | 2,568.45 |
| Oct 2026 | 16,200 | -9.5 | 6.82 | 0.34 | 2,418.31 |
| Oct 2026 | 15,234 | -11.4 | 7.68 | 0.34 | 2,723.48 |
| Oct 2026 | 15,668 | -10.2 | 7.30 | 0.34 | 2,580.04 |
| Oct 2026 | 15,027 | -11.0 | 7.87 | 0.34 | 2,784.76 |
| Oct 2026 | 15,355 | -10.6 | 7.58 | 0.34 | 2,681.41 |
| Oct 2026 | 15,647 | -10.2 | 7.32 | 0.34 | 2,583.04 |
| Oct 2026 | 15,343 | -10.6 | 7.59 | 0.34 | 2,673.15 |
Kestra Medical Technologies, Ltd. Quarterly Results
| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 |
|---|---|---|---|---|
| Revenue | 30,971,000.0 | 28,638,000.0 | 24,552,000.0 | 22,565,000.0 |
| Net Profit | -44,087,000.0 | -38,835,000.0 | -34,166,000.0 | -32,785,000.0 |
| EPS | -0.8 | -0.7 | -0.6 | -0.6 |
Kestra Medical Technologies, Ltd. Revenue & Profit: Last 4 Years
| Line Item | Apr 2026 | Apr 2025 | Apr 2024 | Apr 2023 |
|---|---|---|---|---|
| Revenue | 95,126,000.0 | 59,815,000.0 | 27,814,000.0 | 7,630,000.0 |
| Net Profit | -131,612,000.0 | -113,814,000.0 | -94,120,000.0 | -84,238,000.0 |
| EPS | -2.4 | -5.1 | -5.1 | -4.4 |
Kestra Medical Technologies, Ltd. Balance Sheet
| Line Item | Apr 2026 | Apr 2025 | Apr 2024 | Apr 2023 |
|---|---|---|---|---|
| Total Assets | 358,465,000.0 | 295,744,000.0 | 45,949,000.0 | 38,656,000.0 |
| Total Liabilities | 98,807,000.0 | 90,338,000.0 | 255,326,000.0 | 156,234,000.0 |
| Total Equity | 259,658,000.0 | 205,406,000.0 | -209,377,000.0 | -117,578,000.0 |
Owes vs Owns
Kestra Medical Technologies, Ltd. owed $0.36 for every $1 it owned in Jul 2026, down from $4.04 in Apr 2023.
| Period | Jul 2026 | Apr 2026 | Apr 2025 | Apr 2024 | Apr 2023 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.36× | 0.28× | 0.31× | 5.56× | 4.04× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Kestra Medical Technologies, Ltd. Assets & Liabilities Breakdown (USD millions)
What it owns — Apr 2026
Cash & short-term investments 54.8%Receivables 4.1%Inventory 1.9%Fixed assets (tangible) 17.4%Long-term investments 18.3%Other assets 3.5%
How it's funded — Apr 2026
Long-term debt 11.9%Payables 7.6%Other liabilities 8.0%Shareholders' equity 72.4%
| Line Item | Apr 2026 | Apr 2025 | Apr 2024 | Apr 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 196.4 | 237.6 | 8.2 | 14.8 |
| Receivables | 14.5 | 8.1 | 2.0 | 0.0 |
| Inventory | 6.7 | 6.6 | 3.3 | 2.1 |
| Fixed assets (tangible) | 62.5 | 36.9 | 28.4 | 16.7 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 65.8 | 0.0 | 0.0 | 0.0 |
| Other assets | 12.6 | 6.6 | 4.0 | 5.0 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 0.2 | 0.0 | 20.4 |
| Long-term debt | 42.6 | 41.1 | 42.5 | 17.3 |
| Payables | 27.3 | 24.0 | 23.9 | 6.2 |
| Other liabilities | 28.8 | 25.1 | 188.9 | 112.3 |
| Shareholders' equity | 259.7 | 205.4 | -209.4 | -117.6 |
| Net tangible assets | 259.7 | 205.4 | -209.4 | -117.6 |
Kestra Medical Technologies, Ltd. Cash Flow
| Line Item | Apr 2026 | Apr 2025 | Apr 2024 | Apr 2023 |
|---|---|---|---|---|
| Operating Activities | -81,703,000.0 | -77,608,000.0 | -72,235,000.0 | -69,642,000.0 |
| Investing Activities | -203,277,000.0 | -23,308,000.0 | -12,229,000.0 | -15,461,000.0 |
| Financing Activities | 147,095,000.0 | 330,262,000.0 | 77,725,000.0 | 96,106,000.0 |